Clinical Trial

18F-Pentixafor PET in Hematologic Malignancies

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the efficacy of 18F-Pentixafor PET imaging in the diagnosis, staging and response evaluation of hematological malignancies.
Trial Details
NCT Number NCT07122674
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions Hematological Malignancies
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-14